Re: Sabizabulin - mCRPC- used now for Covid 19.
in response to
by
posted on
Apr 21, 2022 12:46PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
"not sure what you mean by "bunch of bits". Zenith is basically a one molecule company with some royalty preferreds in another company."
Zenith has a number of patents. In the past, did we not refer to it as "Star Factory", the lead pre-clinical compound being ZEN-3694.
Koo